Physicians’ Group Files OPDP Complaint Over 60 Minutes’ Wegovy Segment

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Physicians’ Group Files OPDP Complaint Over 60 Minutes’ Wegovy Segment

J.W. Schomisch

January 24, 2023 at 02:25 PM EST

A physicians’ group filed a “fair balance” complaint with the FDA over a segment on 60 Minutes regarding Novo Nordisk’s obesity drug Wegovy (semaglutide). The Physicians Committee for Responsible Medicine submitted the complaint to the Office of Prescription Drug Promotion (OPDP) on Jan. 19. The complaint alleged “what looked like an ordinary news story about an injectable w... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Physicians’ Group Files OPDP Complaint Over 60 Minutes’ Wegovy Segment

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT